Influence of catheters on predicted tumour control probability and severity of acute genitourinary toxicity during high-dose-rate brachytherapy prostate boost

被引:0
|
作者
Tunio, Mutahir [1 ]
Hashmi, Altaf [1 ]
Rafi, Mansoor [1 ]
Mohsin, Rehan [1 ]
Zameer, Asad [1 ]
机构
[1] Sind Inst Urol & Transplantat, Karachi, Pakistan
关键词
High-dose-rate brachytherapy; prostate; needles; tumour control probability; acute genitourinary toxicity;
D O I
10.1017/S1460396910000312
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: High-dose-rate brachytherapy (HDR) boost is an effective method for dose escalation when treating prostate cancer. Optimal number and location of catheters play key role in radiation dose delivery. We studied the impact of catheters and associated trauma on the dose uncertainties and urethral toxicity. Methods and Materials: Between July 2008 to August 2009, 50 patients with prostate cancer were treated with 46 Gy of external irradiation of whole pelvis (2 Gy per fraction) and two HDR brachytherapy fractions (each 14 Gy) at the end of 10 fractions of external beam. All brachytherapy implants were planned using real-time, ultrasound-based planning system. Variables were prostate and urethral volumes, number of catheters and their mean distance from base of bladder and dose volume histogram parameters. All data were collected during first implant only. The toxicities were graded according to Radiation Therapy Oncology Group Toxicity Criteria. Statistical analysis was done on SPSS version 17.0. Results: The mean number of catheters implanted was 12.38 (8-19), and number of attempts per needle to achieve desired position was 1.6 (range = 0-5). Mean distance between the catheters tips to contrast filled bladder was 3.2 mm (1-8 mm) after the adjustment. Distances >5 mm showed lower doses to prostate and lower predicted tumour control probability (TCP) (p < 0.01). No correlation was found between numbers of catheters implanted, attempts per catheter and severity of acute genitourinary (GU) toxicity. Significant correlation was found between severity of acute GU toxicity and urethral V130, V150 (p < 0.001). Conclusion: Dose decline and subsequently lower TCP were seen for the greater distances between the needles and bladder. Acute GU toxicity increased with higher urethral, but severity of acute GU toxicity does not increase with increase in prostate/urethral volumes, number of catheters needles and attempts.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 50 条
  • [1] High-dose-rate brachytherapy boost for prostate cancer: Outcomes and genitourinary toxicity
    Bece, Andrej
    Patanjali, Nitya
    Jackson, Michael
    Whitaker, May
    Hruby, George
    BRACHYTHERAPY, 2015, 14 (05) : 670 - 676
  • [2] Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer
    Olsen, Johan Staby
    Estefan, Dalia
    Valachis, Antonios
    Jakobsson, Frida
    Karlsson, Leif
    Johansson, Bengt
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (01) : 7 - 14
  • [3] Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity
    Akimoto, T
    Ito, K
    Saitoh, J
    Noda, S
    Harashima, K
    Sakurai, H
    Nakayama, Y
    Yamamoto, T
    Suzuki, K
    Nakano, T
    Niibe, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : 463 - 471
  • [4] PARTIAL VOLUME HIGH-DOSE-RATE BRACHYTHERAPY BOOST FOR LOCALIZED PROSTATE CANCER TOXICITY AND OUTCOME
    Schick, U.
    Popowski, Y.
    Nouet, P.
    Ares, C.
    Dipasquale, G.
    Bieri, S.
    Rouzaud, M.
    Khan, H.
    Weber, D. C.
    Miralbell, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) : 732 - 732
  • [5] Partial Volume High-dose-rate Brachytherapy Boost for Localized Prostate Cancer: Toxicity and Outcome
    Schick, U.
    Popowski, Y.
    Nouet, P.
    Ares, C.
    Dipasquale, G.
    Bieri, S.
    Rouzaud, M.
    Khan, H.
    Weber, D. C.
    Miralbell, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S356 - S357
  • [6] Why stop at using high-dose-rate brachytherapy as a boost for the prostate?
    Beitler, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 4003 - 4004
  • [7] Acute urinary toxicity after high-dose-rate brachytherapy combined with hypofractionated external beam radiation therapy for localized prostate cancer: Relationship between the urethral dose and the severity of acute genitourinary toxicity
    Akimoto, T
    Kitamoto, Y
    Saitoh, J
    Harashima, K
    Sakurai, H
    Nakano, T
    Yamamoto, T
    Ito, K
    Suzuki, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S474 - S474
  • [8] Avoidance of late rectal toxicity after high-dose-rate brachytherapy boost treatment for prostate cancer
    Kragelj, Borut
    Zlatic, Jernej
    Zaletel-Kragelj, Lijana
    BRACHYTHERAPY, 2017, 16 (01) : 193 - 200
  • [9] Evaluation of tolerance and toxicity of high-dose-rate brachytherapy boost combined with interstitial hyperthermia for prostate cancer
    Kukielka, Andrzej Marek
    Hetnal, Marcin
    Bereza, Krzysztof
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (03) : 324 - 330
  • [10] Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
    Yamazaki, Hideya
    Masui, Koji
    Suzuki, Gen
    Yoshida, Ken
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 24 : 10 - 10